Lv2
180 积分 2023-03-30 加入
索凡替尼靶向联合卡培他滨和奥沙利铂治疗肝内胆管癌术后患者1例及文献复习
5个月前
已完结
ASO Visual Abstract: The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study
10个月前
已完结
Interstitial pneumonia disease induced by osimertinib combined with savolitinib targeted therapy in a lung cancer patient: A case report
10个月前
已完结
Toripalimab and fruquintinib therapy for colorectal cancer after failed multiline chemotherapies: a case report
10个月前
已关闭
EGFR-Mutant NSCLC: Chemo–TKI Bests TKI
11个月前
已关闭
Surufatinib combined camrelizumab as a valuable third-line rescue therapy for a patient with extensive-stage for small-cell lung cancer: a case report and literature review
1年前
已完结
SAMETA: A Phase III study of savolitinib + durvalumab vs sunitinib and durvalumab monotherapy in patients with MET-driven, unresectable, locally advanced/metastatic papillary renal cell carcinoma
1年前
已完结
呋喹替尼治疗晚期结直肠癌的疗效及全因死亡的危险因素分析
1年前
已完结
New anti-angiogenic option for mCRC
1年前
已完结
The Treatment of a New Entity in Advanced Non-Small Cell Lung Cancer: MET exon 14 Skipping Mutation
1年前
已关闭
皖公网安备34019202002308
